|
|
||||||||
Ann Thorac Surg 1999;67:182-186
© 1999 The Society of Thoracic Surgeons
a Department of Pharmacy Services, London Health Sciences Centre, London, Ontario, Canada
b Department of Surgery, London Health Sciences Centre, London, Ontario, Canada
c Medicine, London Health Sciences Centre, London, Ontario, Canada
Address reprint requests to Dr Inculet, London Health Sciences Centre, 375 South St, London, Ontario, N6A 4G5, Canada
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2628, 1998.
Background. Prevention of postoperative arrhythmias in patients undergoing general thoracic surgery is desirable to prevent morbidity.
Methods. A randomized, double-blind, placebo controlled trial of propranolol (10 mg every 6 hours) for 5 days was undertaken in patients undergoing major thoracic operations to determine whether arrhythmias requiring treatment could be reduced. Secondary outcomes included overall arrhythmia rate, adverse events, and length of stay. Arrhythmias were assessed by 72-hour Holter monitoring. Patients with a history of heart failure, asthma, advanced heart block, preexisting arrhythmias, sensitivity to propranolol, or use of antiarrhythmic drugs were excluded.
Results. Using the intention-to-treat principle there was a 70% relative risk reduction from 20% to 6% in the rate of treated arrhythmias with propranolol (p = 0.071, 95% confidence interval 0.6% to 27.2%). Overall arrhythmias were common but usually benign. Adverse effects were common, although generally mild with hypotension and bradycardia being reported more often in the propranolol group. Length of stay was not different.
Conclusions. There was a trend to a reduction in the risk of perioperative arrhythmias with propranolol. Moreover, propranolol was well tolerated showing a slight increase in minor adverse events.
This article has been cited by other articles:
![]() |
W. S. Beattie, D. N. Wijeysundera, K. Karkouti, S. McCluskey, and G. Tait Does Tight Heart Rate Control Improve Beta-Blocker Efficacy? An Updated Analysis of the Noncardiac Surgical Randomized Trials Anesth. Analg., April 1, 2008; 106(4): 1039 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Biccard, J. W. Sear, and P. Foex Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes Br. J. Anaesth., January 1, 2008; 100(1): 23 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Fleisher, J. A. Beckman, K. A. Brown, H. Calkins, E. Chaikof, K. E. Fleischmann, W. K. Freeman, J. B. Froehlich, E. K. Kasper, J. R. Kersten, et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation, October 23, 2007; 116(17): e418 - e499. [Full Text] [PDF] |
||||
![]() |
F. Wiesbauer, O. Schlager, H. Domanovits, B. Wildner, G. Maurer, M. Muellner, H. Blessberger, and M. Schillinger Perioperative {beta}-Blockers for Preventing Surgery-Related Mortality and Morbidity: A Systematic Review and Meta-Analysis Anesth. Analg., January 1, 2007; 104(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dunning, T. Treasure, M. Versteegh, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery Eur. J. Cardiothorac. Surg., December 1, 2006; 30(6): 852 - 872. [Full Text] [PDF] |
||||
![]() |
D. Amar, A. Goenka, H. Zhang, B. Park, and H. T. Thaler Leukocytosis and increased risk of atrial fibrillation after general thoracic surgery. Ann. Thorac. Surg., September 1, 2006; 82(3): 1057 - 1061. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Devereaux, W S. Beattie, P. T-L Choi, N. H Badner, G. H Guyatt, J. C Villar, C. S Cina, K. Leslie, M. J Jacka, V. M Montori, et al. How strong is the evidence for the use of perioperative {beta} blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials BMJ, August 6, 2005; 331(7512): 313 - 321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sedrakyan, T. Treasure, J. Browne, H. Krumholz, C. Sharpin, and J. van der Meulen Pharmacologic prophylaxis for postoperative atrial tachyarrhythmia in general thoracic surgery: Evidence from randomized clinical trials J. Thorac. Cardiovasc. Surg., May 1, 2005; 129(5): 997 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Shrivastava, B. Nyawo, J. Dunning, and G. Morritt Is there a role for prophylaxis against atrial fibrillation for patients undergoing lung surgery? Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 656 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al. Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362. [Full Text] [PDF] |
||||
![]() |
M. D. Kertai, E. Boersma, J. J. Bax, I. R. Thomson, M. J. Cramer, L. L. M. van de Ven, M. G. Scheffer, G. Trocino, C. Vigna, H. F. Baars, et al. Optimizing Long-term Cardiac Management After Major Vascular Surgery: Role of {beta}-Blocker Therapy, Clinical Characteristics, and Dobutamine Stress Echocardiography to Optimize Long-term Cardiac Management After Major Vascular Surgery Arch Intern Med, October 13, 2003; 163(18): 2230 - 2235. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Stevens, H. Burri, and M. R. Tramer Pharmacologic Myocardial Protection in Patients Undergoing Noncardiac Surgery: A Quantitative Systematic Review Anesth. Analg., September 1, 2003; 97(3): 623 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Decker, P. G. Jorens, and P. Van Schil Cardiac complications after noncardiac thoracic surgery: an evidence-based current review Ann. Thorac. Surg., April 1, 2003; 75(4): 1340 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Amini, A. Gabrielli, L. J. Caruso, and A. J. Layon The Thoracic Surgical Patient: Initial Postoperative Care Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2002; 6(3): 169 - 188. [Abstract] [PDF] |
||||
![]() |
A. D. Auerbach and L. Goldman {beta}-Blockers and Reduction of Cardiac Events in Noncardiac Surgery: Scientific Review JAMA, March 20, 2002; 287(11): 1435 - 1444. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sekine, K. A. Kesler, M. Behnia, J. Brooks-Brunn, E. Sekine, and J. W. Brown COPD May Increase the Incidence of Refractory Supraventricular Arrhythmias Following Pulmonary Resection for Non-small Cell Lung Cancer Chest, December 1, 2001; 120(6): 1783 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. O. Cheng To use or not to use propranolol for prophylaxis of postthoracotomy arrhythmias Ann. Thorac. Surg., August 1, 1999; 68(2): 627 - 627. [Full Text] [PDF] |
||||
![]() |
R. I. Inculet, D. R. Massel, C. D. Bayliff, and R. A. Malthaner Reply Ann. Thorac. Surg., August 1, 1999; 68(2): 627 - 627. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |